======= NEU3 ======= == Gene Information == * **Official Symbol**: NEU3 * **Official Name**: neuraminidase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10825|10825]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UQ49|Q9UQ49]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NEU3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NEU3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604617|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in modulating the ganglioside content of the lipid bilayer at the level of membrane-bound sialyl glycoconjugates. {ECO:0000269|PubMed:10861246, ECO:0000269|PubMed:20511247}. No Pfam Domain information is available for this gene. |alpha-sialidase activity| |exo-alpha-(2->8)-sialidase activity| |exo-alpha-(2->6)-sialidase activity| |exo-alpha-sialidase activity| |exo-alpha-(2->3)-sialidase activity| |ganglioside catabolic process| |oligosaccharide catabolic process| |glycosphingolipid catabolic process| |glycolipid catabolic process| |ceramide catabolic process| |ganglioside metabolic process| |sphingolipid catabolic process| |membrane lipid catabolic process| |oligosaccharide metabolic process| |glycosphingolipid metabolic process| |ceramide metabolic process| |glycolipid metabolic process| |liposaccharide metabolic process| |carbohydrate catabolic process| |sphingolipid metabolic process| |carbohydrate derivative catabolic process| |cellular lipid catabolic process| |membrane lipid metabolic process| |lipid catabolic process| |carbohydrate metabolic process| |intracellular membrane-bounded organelle| |cellular amide metabolic process| |cellular lipid metabolic process| |carbohydrate derivative metabolic process| |organonitrogen compound catabolic process| |lipid metabolic process| |organic substance catabolic process| |cellular catabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp346|CoCl2 18μM R07 exp346]]|-2.13| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.89| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.78| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-1.74| |[[:results:exp430|Rifampicin 30μM R08 exp430]]|-1.71| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.563| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8279 * **Expression level (log2 read counts)**: 6.86 {{:chemogenomics:nalm6 dist.png?nolink |}}